We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cvs Group Plc | LSE:CVSG | London | Ordinary Share | GB00B2863827 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.53% | 954.00 | 951.00 | 956.00 | 996.00 | 941.00 | 996.00 | 391,692 | 16:07:57 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Veterinary Svcs-animal Specs | 608.3M | 41.9M | 0.5843 | 16.38 | 686.29M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/7/2019 21:11 | JOSEKI , You and I appear to have a different approach to research, we are probably both right.. If it works stick with it.. Obviously we can learn from each other and that is what maters. I have been learning for 40 years and still am. GOOD HUNTING. | bramble13 | |
04/7/2019 18:15 | I don't disagree except sometimes declining P/E doesn't make one immune to value traps. It does apply but depending on nature of company and sector. In the case here, look at the net CFO and with more controlled capex in future what that then means for FCF and ROE. The business top line has done okay in revenue hence the profit and margins are aligned to be positive. | j0sekl | |
04/7/2019 07:15 | Historic values like P/E..PEG and growth over five years give a very good clue as to the health of a company..they have served me extremely well in the past ....We know the past but guess the future, however good your chystal ball is. | bramble13 | |
03/7/2019 19:13 | Focus on execution and fiscally-managed growth. Work your way back to forward P/E rather than historical | j0sekl | |
03/7/2019 13:08 | With a P/E of 17.6, historic P/E has an average of 24.1....I my calculations are that the price could easily reach 900p | bramble13 | |
03/7/2019 07:41 | EAH Peel Hunt Buy 600.0 Reiterates CVSG Peel Hunt Buy 775.00 - Reiterates | grupo | |
28/6/2019 13:26 | The negativity earlier this year included some confusion over why previous reporting disappointed and what were the key strengths. Unless people stop owning pets, the convenience factor will continue to allow for penetration growth. Brexit will eventually resolve and the management team are aware of previous spending levels. It's an easy improvement. | j0sekl | |
28/6/2019 07:24 | Encouraging update! | lomax99 | |
12/5/2019 08:28 | Can you confirm the names in all positions so we know for sure who you refer to? Have you brought this forward to the FCA? -------- To make matters even more incredible CVS’s biggest shareholder Invesco Perpetual and ex-employer to CVS’s Chairman, both directors are budies from PWC audit days) somehow had the timely and opportunistic knack to dump 35 million pounds worth of shares in CVS, co-incidentally seen recent resignation of their current and last company secretaries and head of legal services | j0sekl | |
10/5/2019 06:54 | Why is the City still smarting over CVS Vets and Dignity Funerals? CVS have made great stock, in the past, of bench marking against sister company Dignity Funerals. Then in late 2016 Dignity was on the skids, with questionable practices and pricing and a UK Government investigation by the CMA into the market.The writing was on the wall at Dignity Funeral, it’s shares crashed catastrophically and are now worth 25% of its original share price high. The joint (CVS/Dignity) executives and other directors, seeing the ensuing blood bath and contagion spreading seemingly dumped their shares in CVS vets netting themselves personally millions of pounds. To make matters even more incredible CVS’s biggest shareholder Invesco Perpetual and ex-employer to CVS’s Chairman, both directors are budies from PWC audit days) somehow had the timely and opportunistic knack to dump 35 million pounds worth of shares in CVS, with no questions asked from regulators!CVS Shares have gone down by 2/3rds For shareholders like me who invested in CVS pre their collapse in share price, we are unhappy and asking many difficult questions, which CVS won’t answer! Indeed, I’ve got the needle on CVS and asking all sorts of questions of the senior executives, which has co-incidentally seen recent resignation of their current and last company secretaries and head of legal services (who partly carry the can!) Draw your own conclusions! I've been writing to CVS and asking the dfficult questions and would like to share my further and quite staggering findings into CVS | gilessaint | |
03/5/2019 15:02 | Just bought into this at 660p - seems to be of good value. Fingers crosses. | btfd497 | |
01/4/2019 20:24 | 5% increase in share price from 2pm onwards (9am New York time). 2+2=? | grim | |
01/4/2019 20:24 | 5% increase in share price from 2pm onwards (9am New York time). 2+2=? | grim | |
29/3/2019 16:16 | The rise is a mirror of the size of the previous drop which was way bigger. If they can convert margin improvements, stop splashing cash and begin growing earnings with their decent presence this might move back into the growth premium price range it used to enjoy.. maybe | j0sekl | |
29/3/2019 13:31 | CVS Group PLC (CVSG:LSE): Last: 615.50, up 98.5 (+19.05%), High: 621.00, Low: 542.50, Volume: 1.11m BE The trading update with the interims reads better than expected, with a pick-up in LFL sales, improvement in gross margin and reduction in vacancy rate. This does not remove the issues, but certainly eases any concerns regarding short term issues and the balance sheet. LFL sales in practices +3.2% in H1, with Jan/Feb +c5% helped by price increases and milder weather. We are nudging up our PBT forecast by 3%-5% to reflect the recent improvements. The shares continue to look exceptional value on 8x EV/Ebitda to June 2020E given that recent industry acquisitions for similar businesses are closer to 15x. CVS is an obvious target for the industry consolidators. Shares trading on a PE of 10.7x and 8.1x EV/Ebitda to Jun 2020 12:05 pm BE That's Charles Hall at Peel Hunt. BE "an obvious target for the industry consolidators" .... like? BE I thought CVS itself was the consolidator. 12:06 pm BE And that the consolidation model with vets had all sorts of problems and dis-synergies, as we've banged on about here for what feels like decades. BE Anyway. 12:07 pm | edmondj | |
29/3/2019 13:02 | I can't see anything in the results which justifies a +18% share price rise. What am I missing ? | ramridge | |
29/3/2019 10:35 | Not sure I'm right but things look to be improving and it could easily be prey to someone while it's sub 1000p. | its the oxman | |
29/3/2019 08:50 | I have to say I called that one wrong! lol You could be right, but wait until the next update to really see if things are on the mend. | bulltradept | |
29/3/2019 08:29 | Guess it's relief that things are on the mend at least. Still issues but worst could now be over. | its the oxman | |
29/3/2019 07:36 | Mmmmm result as expected unfortunately. | bulltradept | |
23/3/2019 18:15 | I always take Glassdoor reviews with a pinch of salt. They tend to be the spurned workers who have an axe to grind which does not offer a balanced picture. There are some specific fundamentals that need to be demonstrated by the firm, internal management. Externalities like US data points will prob result in my increasing in stake if negative sentiment dislocates potential growth. But the growth here is all down to execution.. and that so be a critical watch point. | j0sekl | |
14/3/2019 13:35 | Sold a few and made a bit back. Mars are a very different and mature business in this marketplace. You can’t benchmark CVS as a Mars they are way off and my hope is for a takeover for my remainder. May bail before financial results hit as all the predictions for this firm look very gloomy. The US market is very different to the UK the PE space is crowded and the panic buying PFM shares by directors to give faith to investors should send out alarm bells. But will bump the price up prior to the results. | mccookie | |
01/3/2019 10:24 | Why up? Acquisition continues in this hot space, JAB’s Acquire USA Compassion-First Pet Hospitals, which operates 41 veterinary hospitals and emergency clinics in the US, values the company at $1.2bn. And recently seems Goldman Sach increasing stakes in the company. The market cap of around 350million pounds seems undervalued if benchmarking to other recent deals.. Just look at MARS... | compoundinge |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions